Opus Genetics, Inc.
IRD
$0.899
$0.0343.93%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -366.85% | 3.08% | -9.27% | -48.20% | -186.23% |
| Total Depreciation and Amortization | -- | -- | -- | -- | 200.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,277.51% | -3.47% | -18.99% | 44.62% | -62.83% |
| Change in Net Operating Assets | -12.86% | 585.89% | -184.30% | -95.43% | 183.06% |
| Cash from Operations | -44.99% | 29.65% | -27.57% | -225.68% | 251.45% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -70.81% | -36.99% | -34.33% | -31.14% |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 55.34% | -368.18% | 63.93% | 64.53% | -62.26% |
| Cash from Financing | -123.51% | -77.08% | -35.19% | -34.05% | -32.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.11% | 16.95% | -72.22% | -140.98% | 243.49% |